21 CFR § 312.87 Investigational New Drug Application

§ 312.87 Active monitoring of conduct and evaluation of clinical trials.

Current through Sep 8, 2026 · Read all of Part 312

⚠ 4 pending changes to Part 312

For drugs covered under this section, the Commissioner and other agency officials will monitor the progress of the conduct and evaluation of clinical trials and be involved in facilitating their appropriate progress.

← § 312.86 Focused FDA regulatory research.§ 312.88 Safeguards for patient safety. →